141 related articles for article (PubMed ID: 23407766)
1. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.
Ahmad F; Budde U; Jan R; Oyen F; Kannan M; Saxena R; Schneppenheim R
Thromb Haemost; 2013 Apr; 109(4):652-60. PubMed ID: 23407766
[TBL] [Abstract][Full Text] [Related]
2. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients.
Solimando M; Baronciani L; La Marca S; Cozzi G; Asselta R; Canciani MT; Federici AB; Peyvandi F
Am J Hematol; 2012 Sep; 87(9):870-4. PubMed ID: 22674667
[TBL] [Abstract][Full Text] [Related]
4. Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.
Kasatkar P; Shetty S; Ghosh K
PLoS One; 2014; 9(3):e92575. PubMed ID: 24675615
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of mutations and molecular studies of type 2 von Willebrand disease.
Ahmad F; Jan R; Kannan M; Obser T; Hassan MI; Oyen F; Budde U; Saxena R; Schneppenheim R
Thromb Haemost; 2013 Jan; 109(1):39-46. PubMed ID: 23179108
[TBL] [Abstract][Full Text] [Related]
6. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.
Bowman M; Tuttle A; Notley C; Brown C; Tinlin S; Deforest M; Leggo J; Blanchette VS; Lillicrap D; James P;
J Thromb Haemost; 2013 Mar; 11(3):512-20. PubMed ID: 23311757
[TBL] [Abstract][Full Text] [Related]
7. The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England.
Sutherland MS; Keeney S; Bolton-Maggs PH; Hay CR; Will A; Cumming AM
Haemophilia; 2009 Sep; 15(5):1048-57. PubMed ID: 19601990
[TBL] [Abstract][Full Text] [Related]
8. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
[TBL] [Abstract][Full Text] [Related]
9. Two novel mutations identified in a type 3 von Willebrand disease patient.
Ouyang W; Yu Z; Yin J; Su J; Yang C; Ruan C
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):909-11. PubMed ID: 24914743
[TBL] [Abstract][Full Text] [Related]
10. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.
Hampshire DJ; Abuzenadah AM; Cartwright A; Al-Shammari NS; Coyle RE; Eckert M; Al-Buhairan AM; Messenger SL; Budde U; Gürsel T; Ingerslev J; Peake IR; Goodeve AC
Thromb Haemost; 2013 Aug; 110(2):264-74. PubMed ID: 23702511
[TBL] [Abstract][Full Text] [Related]
12. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
[TBL] [Abstract][Full Text] [Related]
14. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations.
Jokela V; Lassila R; Szanto T; Joutsi-Korhonen L; Armstrong E; Oyen F; Schneppenheim S; Schneppenheim R
Haemophilia; 2013 Nov; 19(6):e344-8. PubMed ID: 23834637
[TBL] [Abstract][Full Text] [Related]
16. A novel Alu-mediated 61-kb deletion of the von Willebrand factor (VWF) gene whose breakpoints co-locate with putative matrix attachment regions.
Xie F; Wang X; Cooper DN; Chuzhanova N; Fang Y; Cai X; Wang Z; Wang H
Blood Cells Mol Dis; 2006; 36(3):385-91. PubMed ID: 16690331
[TBL] [Abstract][Full Text] [Related]
17. [Phenotype and genotype analysis of two Chinese pedigrees with type 3 von Willebrand diseases].
Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Wang HL; Xi XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Oct; 29(5):524-8. PubMed ID: 23042386
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
19. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3.
Schneppenheim R; Castaman G; Federici AB; Kreuz W; Marschalek R; Oldenburg J; Oyen F; Budde U
J Thromb Haemost; 2007 Apr; 5(4):722-8. PubMed ID: 17371490
[TBL] [Abstract][Full Text] [Related]
20. Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population.
Mohl A; Boda Z; Jager R; Losonczy H; Marosi A; Masszi T; Nagy E; Nemes L; Obser T; Oyen F; Radványi G; Schlammadinger Á; Szélessy ZS; Várkonyi A; Vezendy K; Vilimi B; Schneppenheim R; Bodó I
J Thromb Haemost; 2011 May; 9(5):945-52. PubMed ID: 21362127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
